Fox Foundation for Parkinson's Research: Therapeutics Development Initiative

Therapeutics Development Initiative - Industry-exclusive for preclinical PD research: Support preclinical development of PD therapies which have the potential for fundamentally altering disease course and/or improving treatment of symptoms above and beyond current standards of care. Proposals must focus on critical preclinical studies necessary for developing, optimizing and evaluating therapeutic strategies that, if successful, can move into human testing. Funding: up to 2 years (may be more) with budget appropriate for the work performed.